EnClear Therapies
Edit

EnClear Therapies

https://www.encleartherapies.com/
Last activity: 21.02.2020
Categories: PersonalMedTechHealthTechHardwareDeliveryBusinessBuildingPlatformStorageTechnology
At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.
Followers
593
Mentions
8
Location: United States, Massachusetts, Newburyport
Employees: 11-50
Total raised: $12M
Founded date: 2018

Investors 6

Funding Rounds 2

DateSeriesAmountInvestors
21.02.2020Series A$10M-
14.03.2019Seed$2M-

Mentions in press and media 8

DateTitleDescriptionSource
21.02.2020Life Sciences Company EnClear Therapies Raises $10 MillionEnClear Therapies — a life sciences company developing device-based therapies for the treatment of n...pulse2.com...
19.02.2020EnClear Therapies Raises $10M in Series A FinancingEnClear Therapies, a Cambridge, Mass.-based life sciences company developing device-based therapies ...finsmes.co...
19.02.2020EnClear Therapies Announces $10M Series A Financing-dolbyventu...
19.02.2020Daily funding roundup - February 19th, 2020Croquet raised $2.7M; BluBracket closed $6.5M; UltraSense Systems landed $20; Maven picks up $45M C...vator.tv/n...
19.02.2020EnClear Therapies Announces $10M Series A FinancingCAMBRIDGE, Mass.--(BUSINESS WIRE)--EnClear Therapies, a life sciences company developing device-base...citybizlis...
26.08.2019Presight Capital raises $80M fund to connect US startups wit...Presight Capital, the international venture arm of Apeiron Investment Group, is announcing that it’s...techcrunch...
25.04.2019Enclear Therapies wins novel device challengeEnClear Therapies’ system designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegen...massdevice...
14.03.2019EnClear Therapies Raises $2M in Seed FundingEnClear Therapies, a Cambridge, MA-based biotechnology company developing device-based therapies for...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In